Symbols / BIMI $0.00 +0.00% BIMI Holdings Inc.

Healthcare • Pharmaceutical Retailers • United States • PNK
BIMI Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Pharmaceutical Retailers
CEO Mr. Tiewei Song
Exch · Country PNK · United States
Market Cap 1.40K
Enterprise Value 5.44M
Income -10.52M
Sales 12.63M
FCF (ttm) -5.75M
Book/sh 1.30
Cash/sh 0.09
Employees 296
Insider 10d —
IPO Jul 23, 2004
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG 2.85
P/S 0.00
P/B 0.00
P/C —
EV/EBITDA -0.80
EV/Sales 0.43
Quick Ratio 0.26
Current Ratio 1.21
Debt/Eq 49.25
LT Debt/Eq —
EPS (ttm) -6.39
EPS next Y —
EPS Growth —
Revenue Growth -48.80%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2011-08-12
Earnings (prior) 2011-08-12
ROA -13.00%
ROE -103.78%
ROIC —
Gross Margin 40.30%
Oper. Margin -124.83%
Profit Margin -83.20%
Shs Outstand 13.96M
Shs Float 1.81M
Insider Own 0.00%
Instit Own 0.00%
Short Float 2.57%
Short Ratio 0.27
Short Interest 153.39K
52W High 0.01
vs 52W High -99.00%
52W Low 0.00
vs 52W Low 0.00%
Beta -0.65
Impl. Vol. —
Rel Volume 20.85
Avg Volume 1.26K
Volume 26.25K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.00
Price $0.00
Change 0.00%
About

BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescription and OTC medicines; TCM; healthcare supplies; traditional Chinese medicines; and sundry items. The Wholesale Pharmaceuticals segment provides prescription; OTC medicines; TCM; healthcare supplies; and sundry items. The Medical Device segment distributes medical devices, including medical consumables. The Healthcare products segment offers dietary supplements comprising cardiovascular products; anti-insomnia and depression products; male aphrodisiac products; menopausal syndrome products; gout products; and immunity products. It sells its products through pharmacies; retail stores; private and government clinics; directly owned stores; third party pharmacies; hospitals; drug wholesalers; and medical device dealers. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. The company was incorporated in 2000 and is based in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-7.41
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2024-06-12 OUDOM FNU Director and Beneficial Owner of more than 10% of a Class of Security — 1,123,500 $1.48 $1,662,780
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2022-12-31 2021-12-31
Total Revenue
11.83
-44.51%
21.32
Operating Revenue
11.83
-44.51%
21.32
Cost Of Revenue
9.88
-47.71%
18.89
Reconciled Cost Of Revenue
9.88
-47.71%
18.89
Operating Expense
11.90
+44.98%
8.21
Selling General And Administration
11.90
+44.98%
8.21
Selling And Marketing Expense
1.30
-39.50%
2.15
General And Administrative Expense
10.60
+75.01%
6.06
Other Gand A
10.60
+75.01%
6.06
Total Expenses
21.78
-19.63%
27.10
Operating Income
-9.95
-72.08%
-5.78
Total Operating Income As Reported
-15.34
+51.94%
-31.91
EBITDA
-17.97
+43.81%
-31.98
Normalized EBITDA
-12.58
-114.10%
-5.87
Reconciled Depreciation
0.22
-8.42%
0.24
EBIT
-18.19
+43.54%
-32.22
Total Unusual Items
-5.39
+79.34%
-26.10
Total Unusual Items Excluding Goodwill
-5.39
+79.34%
-26.10
Special Income Charges
-5.39
+79.39%
-26.13
Impairment Of Capital Assets
5.39
-79.39%
26.13
Net Income
-22.39
+35.99%
-34.99
Pretax Income
-21.62
+37.62%
-34.66
Net Non Operating Interest Income Expense
-3.43
-40.59%
-2.44
Interest Expense Non Operating
3.43
+40.44%
2.44
Net Interest Income
-3.43
-40.59%
-2.44
Interest Expense
3.43
+40.44%
2.44
Interest Income Non Operating
0.00
-77.10%
0.00
Interest Income
0.00
-77.10%
0.00
Other Income Expense
-8.24
+68.84%
-26.44
Other Non Operating Income Expenses
-2.85
-745.34%
-0.34
Gain On Sale Of Security
-0.01
-126.37%
0.02
Tax Provision
0.01
-79.47%
0.03
Tax Rate For Calcs
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-1.35
+79.34%
-6.53
Net Income Including Noncontrolling Interests
-22.32
+36.09%
-34.92
Net Income From Continuing Operation Net Minority Interest
-21.70
+37.56%
-34.76
Net Income From Continuing And Discontinued Operation
-22.39
+35.99%
-34.99
Net Income Continuous Operations
-21.63
+37.66%
-34.69
Net Income Discontinuous Operations
-0.69
-202.31%
-0.23
Minority Interests
-0.08
-17.12%
-0.06
Normalized Income
-17.66
-16.33%
-15.18
Net Income Common Stockholders
-22.39
+35.99%
-34.99
Diluted EPS
-8.38
+87.13%
-65.10
Basic EPS
-8.38
+87.13%
-65.12
Basic Average Shares
2.66
+396.87%
0.54
Diluted Average Shares
2.66
+396.87%
0.54
Diluted NI Availto Com Stockholders
-22.39
+35.99%
-34.99
Line Item Trend 2022-12-31 2021-12-31
Total Assets
35.71
-6.33%
38.13
Current Assets
23.24
+9.81%
21.16
Cash Cash Equivalents And Short Term Investments
2.34
-49.31%
4.61
Cash And Cash Equivalents
2.34
-49.31%
4.61
Cash Financial
—
4.80
Receivables
4.18
-34.20%
6.35
Accounts Receivable
3.21
-45.39%
5.87
Gross Accounts Receivable
4.81
-22.00%
6.17
Allowance For Doubtful Accounts Receivable
-1.60
-442.29%
-0.30
Receivables Adjustments Allowances
-0.02
+8.45%
-0.03
Other Receivables
0.99
+396.39%
0.20
Taxes Receivable
0.00
-100.00%
0.30
Inventory
7.65
+241.91%
2.24
Finished Goods
7.65
+241.91%
2.24
Prepaid Assets
6.97
+130.66%
3.02
Current Deferred Assets
0.00
-100.00%
1.23
Assets Held For Sale Current
2.10
-43.51%
3.72
Total Non Current Assets
12.48
-26.46%
16.97
Net PPE
4.65
+27.13%
3.65
Gross PPE
5.58
+22.94%
4.54
Accumulated Depreciation
-0.94
-5.71%
-0.89
Properties
0.00
0.00
Buildings And Improvements
0.75
-8.46%
0.82
Machinery Furniture Equipment
0.33
-7.42%
0.36
Other Properties
3.90
+41.47%
2.76
Leases
0.60
-1.11%
0.61
Goodwill And Other Intangible Assets
2.08
-75.20%
8.39
Goodwill
2.07
-75.34%
8.38
Other Intangible Assets
0.02
-10.29%
0.02
Investments And Advances
1.80
0.00
Non Current Deferred Assets
—
0.21
Non Current Deferred Taxes Assets
0.19
-8.46%
0.21
Other Non Current Assets
3.76
-20.19%
4.71
Total Liabilities Net Minority Interest
30.50
+13.83%
26.79
Current Liabilities
25.36
+14.80%
22.09
Payables And Accrued Expenses
18.63
+123.91%
8.32
Payables
18.63
+123.92%
8.32
Accounts Payable
10.79
+107.30%
5.20
Other Payable
3.18
+52.69%
2.08
Current Accrued Expenses
-0.00
0.00
Total Tax Payable
0.07
-76.69%
0.31
Current Debt And Capital Lease Obligation
2.57
-62.22%
6.79
Current Debt
2.03
-67.98%
6.35
Other Current Borrowings
1.21
-78.23%
5.58
Current Capital Lease Obligation
0.53
+20.33%
0.44
Current Deferred Liabilities
0.92
-51.26%
1.89
Current Deferred Revenue
0.92
-51.26%
1.89
Other Current Liabilities
3.24
-36.28%
5.08
Total Non Current Liabilities Net Minority Interest
5.13
+9.26%
4.70
Liabilities Heldfor Sale Non Current
2.25
-18.62%
2.76
Long Term Debt And Capital Lease Obligation
2.89
+48.90%
1.94
Long Term Debt
0.31
-41.49%
0.54
Long Term Capital Lease Obligation
2.57
+83.58%
1.40
Stockholders Equity
4.05
-63.84%
11.19
Common Stock Equity
4.05
-63.84%
11.19
Capital Stock
0.00
+342.94%
0.00
Common Stock
0.00
+342.94%
0.00
Share Issued
3.76
+342.80%
0.85
Ordinary Shares Number
3.76
+342.80%
0.85
Additional Paid In Capital
71.90
+30.19%
55.23
Retained Earnings
-70.14
-46.44%
-47.90
Gains Losses Not Affecting Retained Earnings
2.29
-40.80%
3.87
Minority Interest
1.17
+717.88%
0.14
Other Equity Adjustments
2.29
-40.80%
3.87
Total Equity Gross Minority Interest
5.22
-53.98%
11.34
Total Capitalization
4.36
-62.81%
11.73
Working Capital
-2.13
-128.06%
-0.93
Invested Capital
6.40
-64.63%
18.08
Total Debt
5.46
-37.53%
8.73
Net Debt
0.01
-99.50%
2.28
Capital Lease Obligations
3.11
+68.41%
1.85
Net Tangible Assets
1.97
-29.77%
2.80
Tangible Book Value
1.97
-29.77%
2.80
Duefrom Related Parties Current
—
0.62
Dueto Related Parties Current
4.60
+529.95%
0.73
Inventories Adjustments Allowances
—
-0.10
Line Of Credit
0.82
+6.49%
0.77
Line Item Trend 2022-12-31 2021-12-31
Operating Cash Flow
-10.26
-131.14%
-4.44
Cash Flow From Continuing Operating Activities
-10.18
-129.52%
-4.44
Cash From Discontinued Operating Activities
0.00
0.00
Net Income From Continuing Operations
-22.32
+36.09%
-34.92
Depreciation Amortization Depletion
0.22
-8.42%
0.24
Depreciation
0.22
-8.56%
0.24
Amortization Cash Flow
0.00
+1.16%
0.00
Depreciation And Amortization
0.22
-8.42%
0.24
Amortization Of Intangibles
0.00
+1.16%
0.00
Other Non Cash Items
2.66
+18.07%
2.25
Provisionand Write Offof Assets
1.38
+2671.66%
-0.05
Asset Impairment Charge
5.45
-79.23%
26.22
Change In Working Capital
2.35
+29.31%
1.82
Change In Receivables
1.36
+54.70%
0.88
Changes In Account Receivables
1.36
+54.70%
0.88
Change In Inventory
-5.48
-282.93%
-1.43
Change In Prepaid Assets
0.95
-79.75%
4.71
Change In Payables And Accrued Expense
6.46
+257.21%
-4.11
Change In Payable
6.46
+257.21%
-4.11
Change In Account Payable
5.58
+547.11%
-1.25
Change In Other Working Capital
-0.97
-157.11%
1.70
Change In Other Current Assets
-1.23
-1.59%
-1.21
Change In Other Current Liabilities
1.26
-1.62%
1.28
Investing Cash Flow
-0.54
-140.96%
1.31
Cash Flow From Continuing Investing Activities
-0.54
-140.96%
1.31
Cash From Discontinued Investing Activities
0.00
0.00
Net PPE Purchase And Sale
0.00
+100.00%
-0.24
Purchase Of PPE
0.00
+100.00%
-0.24
Capital Expenditure
—
-0.24
Net Business Purchase And Sale
-0.54
+64.49%
-1.51
Purchase Of Business
-1.80
+55.27%
-4.02
Net Other Investing Changes
—
3.07
Financing Cash Flow
8.43
+22.62%
6.88
Cash Flow From Continuing Financing Activities
8.43
+22.62%
6.88
Net Issuance Payments Of Debt
-0.44
-106.70%
6.52
Issuance Of Debt
0.05
-99.25%
6.65
Repayment Of Debt
-0.49
-258.51%
-0.14
Long Term Debt Issuance
0.00
-100.00%
6.65
Long Term Debt Payments
-0.49
0.00
Net Long Term Debt Issuance
-0.49
-107.31%
6.65
Short Term Debt Issuance
0.05
0.00
Short Term Debt Payments
0.00
+100.00%
-0.14
Net Short Term Debt Issuance
0.05
+136.76%
-0.14
Net Common Stock Issuance
5.00
0.00
Net Other Financing Charges
3.87
+970.37%
0.36
Changes In Cash
-2.36
-162.86%
3.75
Effect Of Exchange Rate Changes
0.09
-88.14%
0.72
Beginning Cash Position
4.61
+3306.60%
0.14
End Cash Position
2.34
-49.31%
4.61
Free Cash Flow
-10.26
-119.15%
-4.68
Interest Paid Supplemental Data
0.16
-0.34%
0.16
Income Tax Paid Supplemental Data
0.01
-98.56%
0.42
Change In Income Tax Payable
-0.22
+54.35%
-0.48
Change In Tax Payable
-0.22
+54.35%
-0.48
Common Stock Issuance
5.00
0.00
Issuance Of Capital Stock
5.00
0.00
Sale Of Business
1.26
-49.72%
2.51
Cash From Discontinued Financing Activities
0.00
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category